|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
22,520,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NexImmune is a clinical-stage biotechnology company developing an approach to immunotherapy designed to employ the body's own T cells to generate a specific immune response that mimics natural biology. Co. has two product candidates: NEXI-001 in acute myeloid leukemia, and NEXI-002 in multiple myeloma. Co.'s product candidates are adoptive T cell therapies (ACTs) that contain populations of naturally occurring CD8+ T cells that recognize a defined set of disease-relevant antigen targets. In addition to its programs using the Artificial Immune Modulation (AIM) ACT adoptive cell therapy modality, Co. is also developing an off-the-shelf injectable modality, which it refers to as AIM INJ.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
500,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$768,230 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
11 |
| Total Shares Sold |
0 |
7,825 |
7,825 |
7,825 |
| Total Sell Value |
$0 |
$16,045 |
$16,045 |
$16,045 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
2 |
2 |
2 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barer Sol J |
Director |
– • – |
2021-12-21 |
4 |
OE |
$5.17 |
$258,500 |
D/D |
50,000 |
1,417,814 |
|
- |
|
| Trainer John |
Chief Financial Officer |
• – – |
2021-07-08 |
4 |
OE |
$5.17 |
$17,743 |
D/D |
3,432 |
61,770 |
|
- |
|
| Trainer John |
Chief Financial Officer |
• – – |
2021-06-08 |
4 |
OE |
$5.17 |
$17,743 |
D/D |
3,432 |
58,338 |
|
- |
|
| Trainer John |
Chief Financial Officer |
• – – |
2021-05-08 |
4 |
OE |
$5.17 |
$17,743 |
D/D |
3,432 |
54,906 |
|
- |
|
| Trainer John |
Chief Financial Officer |
• – – |
2021-04-08 |
4 |
OE |
$5.17 |
$17,743 |
D/D |
3,432 |
51,474 |
|
- |
|
| Trainer John |
Chief Financial Officer |
• – – |
2021-03-10 |
4 |
OE |
$5.17 |
$17,743 |
D/D |
3,432 |
48,042 |
|
- |
|
| Zeldis Jerome B |
Executive VP of Research & Dev |
• – – |
2021-02-17 |
4 |
B |
$17.00 |
$99,994 |
D/D |
5,882 |
5,882 |
2.74 |
- |
|
| Verstandig Grant |
Director |
– • – |
2021-02-17 |
4 |
B |
$17.00 |
$2,975,000 |
D/D |
175,000 |
714,895 |
2.39 |
- |
|
| Verstandig Grant |
Director |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
539,895 |
539,895 |
|
- |
|
| Jones Kristi |
Chief Operating Officer |
• – – |
2021-02-17 |
4 |
B |
$17.00 |
$15,487 |
D/D |
911 |
63,078 |
2.74 |
- |
|
| Jones Kristi |
Chief Operating Officer |
• – – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,738 |
62,167 |
|
- |
|
| Barer Sol J |
Director |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,695,583 |
346,577 |
|
- |
|
| Barer Sol J |
Director |
– • – |
2021-02-17 |
4 |
B |
$17.00 |
$1,020,000 |
I/I |
60,000 |
1,538,013 |
2.1 |
- |
|
| Barer Sol J |
Director |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
800,182 |
1,367,814 |
|
- |
|
| Carmer Scott |
President and CEO |
• • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,058 |
7,058 |
|
- |
|
| Bertram Timothy |
Director |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
71,749 |
78,199 |
|
- |
|
| Dangio Paul |
Director |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
27,847 |
27,847 |
|
- |
|
| Roemer Alan S. |
Director |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
127,984 |
127,984 |
|
- |
|
| Barer Sol J |
Director |
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
129,007 |
|
- |
|
| Barer Sol J |
Director |
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
567,632 |
|
- |
|
| Trainer John |
Chief Financial OfficerOfficer |
• – – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
44,611 |
|
- |
|
| Jones Kristi |
Chief Operating OfficerOfficer |
• – – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
47,429 |
|
- |
|
| Yao Zhengbin |
Director |
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,634 |
|
- |
|
| Bertram Timothy |
Director |
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,450 |
|
- |
|
49 Records found
|
|
Page 2 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
